KRON - Kronos Bio GAAP EPS of -$0.54 misses by $0.03 revenue of $0.92M misses by $0.48M
2023-11-14 02:12:30 ET
More on Kronos Bio
- Kronos to cut 19% of workforce, focus on drugs KB-0742, lanraplenib
- Kronos Bio stock slightly up on positive preliminary data for investigational cancer drug
- Seeking Alpha’s Quant Rating on Kronos Bio
- Historical earnings data for Kronos Bio
- Financial information for Kronos Bio
For further details see:
Kronos Bio GAAP EPS of -$0.54 misses by $0.03, revenue of $0.92M misses by $0.48M